Variables   DRP Crude OR (95% CI) p-value
    Yes No    
Regimen deviation   118 (76.1%) 37 (23.9%) 1.16 (0.72-1.87) 0.545
Inappropriate BSA   28 (100%) 0 (0%)   0.998
* undetermined metastasis stage   136 (74.3%) 47 (25.7%) 1 (0.64-1.64) 0.929
Use of in appropriate lab results   17 (94.4%) 1 (5.6%) 6.133 (0.805-46.74) 0.08
Sex Male 139 (77.2%) 41 (22.8%) 1  
  Female 133 (71.9%) 52 (28.1%) 1.326 (0.83-2.13) 0.243
Age 70-79 4 (80%) 1 (20%) 1.4 (0.15-12.9) 0.769
  60-69 31 (83.8%) 6 (16.2%) 1.8 (0.697-4.65) 0.224
  50-59 80 (72.1%) 31 (27.9%) 0.9 (0.52-1.57) 0.709
  40-49 48 (73.8%) 17 (26.2%) 0.98 (0.51-1.9) 0.963
  < 40 109 (74.1%) 38 (25.9%) 1 0.722
Co-morbidity Yes 69 (88.5%) 9 (11.5%) 3.2 (1.514-6.65) 0.002
Hospital stay 1-2 142 (67.9%) 67 (32.1%) 1  
(days) 3-10 130 (83.3%) 26 (16.7%) 2.36 (1.414-3.94) 0.001
No. of Meds       1.4 (1.0-1.85) 0.02
           
*undetermined metastasis stage indicates metastasis stage is unknown or not described in patient chart
Table 4: Univariate Logistic Regression results for individual risk factors.